Alpha Mark Advisors, LLC Alkermes Plc. Transaction History
Alpha Mark Advisors, LLC
- $288 Million
- Q2 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 12,781 shares of ALKS stock, worth $368,476. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,781
Previous 10,976
16.44%
Holding current value
$368,476
Previous $297,000
3.7%
% of portfolio
0.11%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$839 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$577 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$414 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$317 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$266 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.74B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...